Drug Shortage Report for IRBESARTAN-HCTZ
| Report ID | 126054 |
| Drug Identification Number | 02365170 |
| Brand name | IRBESARTAN-HCTZ |
| Common or Proper name | IRBESARTAN-HCTZ |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN HYDROCHLOROTHIAZIDE |
| Strength(s) | 300MG 12.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-09 |
| Estimated end date | 2020-10-29 |
| Actual end date | 2020-10-29 |
| Shortage status | Resolved |
| Updated date | 2020-10-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-10-30 | English | Compare |
| v6 | 2020-10-29 | French | Compare |
| v5 | 2020-10-29 | English | Compare |
| v4 | 2020-10-29 | English | Compare |
| v3 | 2020-10-10 | English | Compare |
| v2 | 2020-10-09 | French | Compare |
| v1 | 2020-10-09 | English | Compare |
Showing 1 to 7 of 7